Enhanced SHP-1 Expression in Podocyturia Is Associated with Kidney Dysfunction in Patients with Diabetes.
Farah LizotteStéphanie RobillardNicolas LavoieMarina RousseauBenoit DenhezJulie MoreauSarah HigginsRobert SabbaghAnne-Marie CôtéPedro GeraldesPublished in: Kidney360 (2022)
Levels of SHP-1 in urinary podocytes may serve as an additional marker of glomerular disease progression in this population.